NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (NRXP)

CUSIP: 629444209

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 7 signals
Share change
+5,394,607
Put/Call ratio
17%
SEC-reported price per share
$4.09
Number of holders
47
Value change
+$22,247,954
Number of buys
36
Open additional details 1 more signal available
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,443,612

Security key

629444209

Report period

Q2 2026

Institutions

47

Top holders

10

Ownership snapshot

Top reported holders of NRXP - NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
B Group, Inc.
Disclosed value leader
B Group, Inc.
Comparable rows
2/15
Latest evidence
31 Mar 2026
3/4/5 13D/G 13F Lead comparable stake: 13% 13 rows are not safely comparable across share classes. 13D/G row: B Group, Inc. Showing 1-6 of 15 holder rows.

Quick read

B Group, Inc. leads the comparable SEC ownership view at 13%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens B Group, Inc.'s linked filing trail.
Comparable ownership Top 2
B Group, Inc. 13%
Anson Funds Management LP 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
B Group, Inc.
3/4/5 13D/G 13F
10%+ Owner · The B Group, Inc. · Company
13%
Reported 13D/G · 18 Aug 2025
$8,820,000
3,000,000 shares
— 18 Aug 2025
Anson Funds Management LP
13D/G
4.9%
Reported 13D/G · 31 Mar 2026
$3,855,556
1,736,737 shares
+$292,512 31 Mar 2026
Daniel C. Javitt
3/4/5
10%+ Owner
—
denominator unverified
$3,082,170
9,634,793 shares
— 29 Nov 2022
Jonathan C. Javitt
3/4/5
Chairman and Chief Scientist, Director, 10%+ Owner
—
mixed-class rows
$1,774,696
1,641,834 shares
mixed-class rows
— 09 Apr 2025
BRAC Lending Group LLC
3/4/5
10%+ Owner
—
denominator unverified
$188,880
590,435 shares
— 24 May 2021
Big Rock Partners Sponsor, LLC
3/4/5
10%+ Owner
—
mixed-class rows
$166,129
619,315 shares
mixed-class rows
— 24 May 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
47
Shares
11,638,886
Rows available
47
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
32
Q2 2026 holders
47
Holder diff
15
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .